As is the case in many inflammatory and infectious diseases, a variety of inflammatory and thrombosis-related signaling molecules are released from platelets and other cell types in COVID-19 patients, including serotonin, platelet factor 4, and monocyte chemoattractant protein 1 (5, 7, 12–14). The gene discussed is PF4; the disease is COVID-19.